Elanco invites all stakeholders to explore the full 2024 Impact Report and looks forward to further advancing our purpose of Making Life Better for animals, customers, society, and our people in ...

Elanco Animal Health (NYSE:ELAN) Incorporated (NYSE: ELAN) shares have reached a 52-week low, dipping to $11.11, as the company faces a tumultuous market environment. With a market capitalization ...

Fintel reports that on June 26, 2025, William Blair upgraded their outlook for Elanco Animal Health (NYSE:ELAN) from Market ...

Elanco upgraded to Outperform by William Blair as pipeline gains traction and EMA backs Zenrelia ahead of expected Q3 approval.

Elanco Animal Health is expecting new products to contribute between $600 and $700 million in revenue in 2025. ELAN Q3/24 Presentation. Management expects revenue growth in 2025 to accelerate to ...

In the first year, Canine Parvovirus Monoclonal Antibody saved thousands of puppies GREENFIELD, Ind., Oct. 15, 2024 /PRNewswire/ -- Elanco Animal Health today unleashed the first ever real-world ...

GREENFIELD, Ind., May 28, 2025 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today announced the appointment of Robert VanHimbergen as Executive Vice President and Chief Financial ...

Elanco Animal Health Incorporated (NYSE: ELAN) announced the release of its 2024 Impact Report, showcasing its efforts to ...

GREENFIELD, Ind., May 28, 2025 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today announced the appointment of Robert VanHimbergen as Executive Vice President and Chief Financial ...